Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
André J. Scheen. (2017) Dapagliflozin and saxagliptin tablets for adults with type 2 diabetes. Expert Review of Clinical Pharmacology 10:12, pages 1303-1316.
Read now
Read now
André J. Scheen. (2017) Pharmacokinetic drug evaluation of saxagliptin plus dapagliflozin for the treatment of type 2 diabetes. Expert Opinion on Drug Metabolism & Toxicology 13:5, pages 583-592.
Read now
Read now
André J. Scheen. (2016) DPP-4 inhibitor plus SGLT-2 inhibitor as combination therapy for type 2 diabetes: from rationale to clinical aspects. Expert Opinion on Drug Metabolism & Toxicology 12:12, pages 1407-1417.
Read now
Read now
Avivit Cahn, Simona Cernea & Itamar Raz. (2016) An update on DPP-4 inhibitors in the management of type 2 diabetes. Expert Opinion on Emerging Drugs 21:4, pages 409-419.
Read now
Read now
Robert M. Guthrie. (2015) Practice pearl: the effect of canagliflozin on HbA1c and blood pressure in patients with type 2 diabetes mellitus. Postgraduate Medicine 127:8, pages 783-785.
Read now
Read now
Articles from other publishers (5)
Kasper S Madsen, Pernille Kähler, Lise Katrine Aronsen Kähler, Sten Madsbad, Filip Gnesin, Maria-Inti Metzendorf, Bernd Richter & Bianca Hemmingsen. (2019) Metformin and second- or third-generation sulphonylurea combination therapy for adults with type 2 diabetes mellitus. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Evangelia Kalaitzoglou, John L. Fowlkes, Iuliana Popescu & Kathryn M. Thrailkill. (2019) Diabetes pharmacotherapy and effects on the musculoskeletal system. Diabetes/Metabolism Research and Reviews 35:2, pages e3100.
Crossref
Crossref
André J. Scheen. (2016) Pharmacokinetic Characteristics and Clinical Efficacy of an SGLT2 Inhibitor Plus DPP-4 Inhibitor Combination Therapy in Type 2 Diabetes. Clinical Pharmacokinetics 56:7, pages 703-718.
Crossref
Crossref
Kathryn M. Thrailkill, Jeffry S. Nyman, R. Clay Bunn, Sasidhar Uppuganti, Katherine L. Thompson, Charles K. LumpkinJrJr, Evangelia Kalaitzoglou & John L. Fowlkes. (2017) The impact of SGLT2 inhibitors, compared with insulin, on diabetic bone disease in a mouse model of type 1 diabetes. Bone 94, pages 141-151.
Crossref
Crossref
Xiao Meng, Yu Qian, Li-Shi Jiang, Jin-Mei Kang, Yan Chen, Juan Wang, Shu-Kun Liu, Zhen-Ming Che & Xin Zhao. (2016) Effects of Lactobacillus plantarum SCS2 on blood glucose level in hyperglycemia mice model. Applied Biological Chemistry 59:1, pages 143-150.
Crossref
Crossref